Module 5: Monitoring and Evaluation

Lesson 2

Aberrant drug-related behaviour (cont’d)

Additional aberrant drug-related behaviours can be found on the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain, appendix B-10. Principles related to opioids as an example may be generalizable to behaviours with other controlled substances.

If a prescriber is concerned about aberrant drug behaviour, a validated tool such as the SOAPP-R for assessment may be considered. The SOAPP-R is an instrument that can help clinicians identify patients who may require extra monitoring and management (Michna et al., 2004).